ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Unicredit Bank AG

Unicredit Bank AG (UC5F0R)

0.968
0.00
(0.00%)
Closed March 15 12:30PM
Most recent streaming
Time Price Size Type Bid Price Ask Price B/S Buy Ind. Total Volume Num Exch.

Your Recent History

Delayed Upgrade Clock
Play Episode
5min
Proactive - Interviews for investors
Empire Metals MD on high-purity titanium breakthrough
Empire Metals Ltd (AIM:EEE) managing director Shaun Bunn talked with Proactive about the company's latest metallurgical test results at the Pitfield project. The test work delivered an impressive 91.6% purity titanium dioxide compound—achieved on the first attempt. Bunn emphasised that this high-grade product is free from deleterious contaminants, making it suitable for further processing into titanium sponge metal or premium-grade titanium pigments. He explained that the team successfully extracted and refined the titanium-bearing minerals using gravity separation, flotation, and acid digestion techniques. The company is now focused on optimising its processing flow sheet and scaling up test work. Recent bulk metallurgical sample collections at Pitfield will support larger-scale testing, with the goal of producing more of this high-grade product for market analysis. Bunn also highlighted that the simplicity of Pitfield's mineral composition, free from heavy metals or radioactive elements, has contributed to the rapid progress in refining processes. With further purification testing ahead, Empire Metals is poised to advance its titanium strategy. For more insights from this interview, visit Proactive’s YouTube channel. Don't forget to like, subscribe, and turn on notifications for future updates. #EmpireMetals #Titanium #Mining #PitfieldProject #Metallurgy #TitaniumDioxide #MineralProcessing #MiningStocks #TitaniumSponge #Investing
Proactive - Interviews for investors
Clinical study SKNJCT-003 shows positive trends as company advances skin cancer research in UAE
Medicus Pharma CEO Dr. Raza Bokhari joined Steve Darling from Proactive to share updates on the ongoing SKNJCT-003 clinical study, which is being conducted at nine sites across the United States and aims to randomize 60 patients. An interim analysis conducted after enrolling more than half of the targeted participants has shown encouraging results. The study reports a clinical clearance rate exceeding 60%, with the investigational therapy demonstrating strong tolerability across both tested dosage levels. Notably, no dose-limiting toxicities (DLTs) or serious adverse events (SAEs) have been observed, and there have been no systemic effects or clinically significant abnormalities in laboratory results, ECGs, vital signs, or physical exams. These promising findings will be submitted to the U.S. Food and Drug Administration (FDA) as part of a Type C meeting request in Q2 2025. In parallel, the company is advancing its clinical initiatives for non-invasive basal cell carcinoma treatment with a newly proposed study. This randomized, double-blind, placebo-controlled, multi-center trial has been submitted for approval to the UAE Department of Health. The study aims to enroll up to 36 patients at prominent medical institutions, including Cleveland Clinic Abu Dhabi, Sheikh Shakbout Medical City, Burjeel Medical City, and the American Hospital of Dubai. Participants will be assigned in a 1:1:1 ratio to receive either a placebo or one of two dosage levels of the experimental treatment. This expansion into the UAE represents a significant step forward in the company’s mission to develop innovative, non-invasive therapies for skin cancer, broadening its global clinical footprint and reinforcing its commitment to advancing patient care. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #Biotech #CancerTreatment #ClinicalTrials #FDAApproval #SkinCancer #HealthcareInnovation #Investing #MedicalResearch
Proactive - Interviews for investors
HIVE Digital reports 89 BTC mined in February, plans 4x hashrate expansion by September 2025
Hive Digital Technologies Executive Chairman Frank Holmes joined Steve Darling from Proactive to discuss the company’s unaudited Bitcoin production results for February 2025. HIVE mined 89 BTC during the month, bringing its total Bitcoin holdings to 2,620 BTC, valued at approximately $220 million as of February 28, based on a BTC price of $84,000. Holmes highlighted that HIVE's Bitcoin holdings have grown by 23% year-over-year. However, on a month-over-month basis, BTC reserves declined as the company strategically sold a portion of its holdings to reinvest in capital assets, including acquiring Bitfarms’ 200 MW hydro-powered Bitcoin mining facilities in Paraguay. Despite the asset reallocation, HIVE maintained a strong mining capacity, averaging 5.6 Exahash per Second (EH/s) with fleet efficiency at 20.9 Joules per Terahash. The company achieved a peak BTC-only hashrate of 6.2 EH/s and a peak BTC-equivalent hashrate of 6.4 EH/s, with an average daily production rate of 3.2 BTC—equivalent to 16 BTC per Exahash. Looking ahead, HIVE is targeting significant growth in 2025, with plans to quadruple its hashrate from 6 EH/s to 25 EH/s by September. The company’s 300 MW expansion in Paraguay is a key part of this strategy, with phased energization of miners set for calendar Q2 2025. The first 100 MW will be deployed at Yguazú, followed by another 100 MW at Valenzuela, positioning HIVE for substantial scale-up in the competitive Bitcoin mining landscape. #proactiveinvestors #hivedigitaltechnologieslet #tsxv #hive #nasdaq #hive
Proactive - Interviews for investors
Frontier IP investee GraphEnergyTech discusses solar panel collaboration
GraphEnergyTech CEO Dr Thomas Baumeler discussed a collaboration with the Taiwan Perovskite Solar Corporation, Taiwan’s prestigious Industrial Technology Research Institute and the University of Cambridge. The project is supported by an Innovate UK grant worth nearly £900,000. Known as GETPSC (Graphene Electrode Technology for Perovskite Solar Cells), Baumeler explained that current solar cells rely on expensive silver electrodes, which degrade when in contact with Perovskite Solar Cells. GraphEnergyTech, a Frontier IP Group PLC (AIM:FIPP) portfolio company, aims to replace these with graphene-based electrodes, offering a more stable and cost-effective alternative. "Graphene is one of the most interesting materials out there," he said, highlighting its durability and lower cost compared to silver. Perovskite Solar Cells are considered the next major advancement in photovoltaics due to their efficiency and simpler manufacturing process. However, industrial-scale adoption has been hindered by the lack of a viable nonmetallic electrode—something GraphEnergyTech aims to solve. Baumeler also noted that GraphEnergyTech is working on replacing silver electrodes in traditional silicon-based solar cells while exploring applications for its conductive carbon-based technology in batteries, supercapacitors, and electronics. For more insights into renewable energy innovations, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and enable notifications for future updates. #GraphEnergyTech #SolarEnergy #GrapheneTech #PerovskiteSolar #RenewableEnergy #CleanEnergy #TechInnovation #SolarCells #GreenTechnology #EnergyStorage